HomeInsightsStock Comparison

Medicamen Organics Ltd vs Panacea Biotec Ltd Stock Comparison

Medicamen Organics Ltd vs Panacea Biotec Ltd Stock Comparison

Last Updated on: Jun 14, 2025

Key Highlights

  • The Latest Trading Price of Medicamen Organics Ltd is ₹ 46.05 as of 13 Jun 15:30.
  • The P/E Ratio of Medicamen Organics Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Panacea Biotec Ltd changed from 0.8 on March 2022 to 0 on March 2024 . This represents a CAGR of -100.00% over 3 years.
  • The Market Cap of Medicamen Organics Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Panacea Biotec Ltd changed from ₹ 670.7 crore on March 2020 to ₹ 742.97 crore on March 2024 . This represents a CAGR of 2.07% over 5 years.
  • The revenue of Medicamen Organics Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Panacea Biotec Ltd for the Mar '25 is ₹ 168.83 crore as compare to the Dec '24 revenue of ₹ 169.88 crore. This represent the decline of -0.62%.
  • The ebitda of Medicamen Organics Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Panacea Biotec Ltd for the Mar '25 is ₹ 9.42 crore as compare to the Dec '24 ebitda of ₹ 14.35 crore. This represent the decline of -34.36%.
  • The net profit of Medicamen Organics Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Panacea Biotec Ltd changed from ₹ 10.98 crore to ₹ -1.99 crore over 8 quarters. This represents a CAGR of NaN% .
  • The Dividend Payout of Medicamen Organics Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Panacea Biotec Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Medicamen Organics Ltd

  • Medicamen Organics Limited was formerly incorporated on March 15, 1995 as Panchdeep Pharmaceuticals Limited', as Public Limited Company dated March 15, 1995 issued by the Registrar of Companies, Delhi and Haryana.
  • Subsequently, the name of Company changed to Medicamen Organics Limited' and a fresh Certificate of Incorporation on November 14, 1995 was issued by the Registrar of Companies, Delhi and Haryana at Delhi. Medicamen Organics are engaged in developing, manufacturing and distribution of broad range of pharmaceutical dosage including generic dosage in form of Tablets, Capsules, Oral Liquids, Ointments, Gel, Syrups, Suspension and Dry Powders for Government (including both State and Central Governments) and Private Institutions as contract manufacturer / third party manufacturer.
  • The Company market product to private pharma companies in domestic as well as international markets through third party distributors or on loan license basis.

About Panacea Biotec Ltd

  • India's leading research-based health management company with established research, manufacturing and marketing capabilities are collectively known as Panacea Biotec Limited (PBL), which was incorporated on February 2, 1984 under the name of Panacea Drug (P) Ltd. A second largest vaccine producer in India has the product portfolio of highly innovative prescription products in important therapeutic areas such as pain management, diabetes management, renal-disease management, anti-osteoporosis, anti-tubercular, gastro-intestinal care products and vaccines.
  • The Company has collaborations and tie-ups with leading national and international research organizations and corporations.
  • PBL has ultra modern, state-of-art production facilities at Himachal Pradesh, Punjab & Delhi for manufacturing vaccines and pharmaceutical formulations comply with the US-FDA, UK-MHRA, SAMCC and WHO-cGMP standards and it has four research and development centers.

Medicamen Organics Ltd News Hub

News

Medicamen Organics to convene board meeting

Medicamen Organics will hold a meeting of the Board of Directors of the Company on 29 May ...

Read more

27 May 2025 11:04

News

Medicamen Organics to hold board meeting

Medicamen Organics will hold a meeting of the Board of Directors of the Company on 8 Janua...

Read more

04 Jan 2025 10:28

News

Medicamen Organics to discuss results

Medicamen Organics will hold a meeting of the Board of Directors of the Company on 14 Nove...

Read more

09 Nov 2024 14:44

News

Medicamen Organics to conduct AGM

Medicamen Organics announced that the 29th Annual General Meeting (AGM) of the company wil...

Read more

27 Aug 2024 16:29

News

NSE SME Medicamen Organics soars on debut

The scrip was listed at Rs 137.85, a premium of 305.44% over the initial public offer (IPO...

Read more

28 Jun 2024 12:45

Panacea Biotec Ltd News Hub

News

Panacea Biotec announces inclusion of EmulsiPan into prestigious CEPI Adjuvant Library

Panacea Biotec announced the listing of EmulsiPan in the CEPI (Coalition for Epidemic Prep...

Read more

03 Jun 2025 12:08

News

Panacea Biotec declare Quarterly Result

Panacea Biotec will hold a meeting of the Board of Directors of the Company on 30 May 2025...

Read more

26 May 2025 17:09

News

Panacea Biotec to announce Quarterly Result

Panacea Biotec will hold a meeting of the Board of Directors of the Company on 14 February...

Read more

01 Feb 2025 10:27

News

Panacea Biotec Pharma launches 'NikoMom' brand of baby diapers and wipes

Panacea Biotec announced that the company's wholly owned subsidiary, Panacea Biotec Pharma...

Read more

03 Jan 2025 15:24

News

Panacea Biotec announces investment in Panacea Biotec Inc.

Panacea Biotec announced that the company's material subsidiary, Panacea Biotec Pharma (PB...

Read more

28 Dec 2024 14:00

News

Panacea Biotec hits the roof on bagging order worth Rs 127-cr from UNICEF

The company will supply 115 million doses of bivalent oral polio vaccine (bOPV) in Africa ...

Read more

26 Dec 2024 10:30

SWOT Analysis Of Panacea Biotec Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Medicamen Organics Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Medicamen Organics Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Panacea Biotec Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Medicamen Organics Ltd and Panacea Biotec Ltd

Which company has a larger market capitalization, Medicamen Organics Ltd or Panacea Biotec Ltd?

Market cap of Medicamen Organics Ltd is 53 Cr while Market cap of Panacea Biotec Ltd is 2,767 Cr

What are the key factors driving the stock performance of Medicamen Organics Ltd and Panacea Biotec Ltd?

The stock performance of Medicamen Organics Ltd and Panacea Biotec Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Medicamen Organics Ltd and Panacea Biotec Ltd?

As of June 14, 2025, the Medicamen Organics Ltd stock price is INR ₹46.05. On the other hand, Panacea Biotec Ltd stock price is INR ₹451.8.

How do dividend payouts of Medicamen Organics Ltd and Panacea Biotec Ltd compare?

To compare the dividend payouts of Medicamen Organics Ltd and Panacea Biotec Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions